Allurion is incorporated in Delaware.
Allurion's corporate headquarters are located at 11 Huron Drive, Natick MA 01760.
Allurion common stock trades on the New York Stock Exchange under the ticker ALUR.
Allurion's CUSIP number is 204833107.
Allurion’s auditor is Deloitte LLP, 200 Berkeley Street, Boston MA 02116.
Allurion’s transfer agent is Continental Stock Transfer & Trust Company. They can be reached by phone at (212) 509-4000 or by email at cstmail@continentalstock.com.
Shares of Allurion can be purchased through the broker of your choice.
Allurion’s fiscal year end is December 31.
To review Allurion’s corporate governance policies, please visit the Corporate Governance section of the website.
Quarterly and annual reports and other investor materials are available under the SEC Filings section. Additionally, all SEC filings can also be viewed directly on the SEC website at www.sec.gov.
Earnings call information, including details for accessing the conference call and/or webcast, will be available in the Events & Presentations section of our website.
If you wish to contact Allurion’s investor relations team, please send an email to investors@allurion.com.
Please visit the Events & Presentations section of our website.